United States Sperm Bank Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The U.S. sperm bank market forms the core of the North American assisted reproduction sector, supplying donor sperm to fertility clinics, obstetric practices, and individuals pursuing at-home insemination. Valued at approximately $5.0 billion in 2025, the market is projected to grow at a compound annual growth rate of roughly 3.5%, with the wider global market on track to reach around $8 billion by 2030. Because no U.S. federal agency compiles centralized economic statistics on the sector, market sizing is generated by private research firms and observed through clinic and cryobank revenue disclosures.

• •North America accounts for the largest share of global revenue, anchored by the United States.
• •Service offerings include donor recruitment, genetic and health screening, cryopreservation, online catalog distribution, and direct-to-consumer shipping.

The strongest demand-side driver is the continued rise in infertility rates, which the CDC attributes in part to delayed childbearing, environmental exposures, and lifestyle factors. Supply-side growth is supported by widespread insurance coverage or financing for assisted reproductive technologies, expanding LGBTQ+ family-building pathways, the 2022 overturning of California's donor anonymity law, and steady improvements in sperm freezing, sex-sorting, and genetic screening technologies. Single women and same-sex couples now represent a fast-growing customer segment, and employer-sponsored fertility benefits continue to broaden the addressable market.

• •Declining fertility rates and older average maternal age increase demand for donor sperm across all U.S. regions.
• •California Cryobank, Fairfax Cryobank, Cryos International, and others have expanded genetic and ancestry testing panels, raising per-unit revenue and improving customer retention.

Revenue is generated across three primary channels: fertility clinics and physician practices, individual consumers (including single mothers by choice and LGBTQ+ couples), and international exports, in which U.S. cryobanks serve markets in Europe, Latin America, and Asia. By service type, the market splits between known donors, open-identity donors (who agree to be contacted after the child turns 18), and fully anonymous donors. Geographically, California, New York, Texas, Florida, and Illinois lead volume due to dense populations of fertility clinics, large donor pools, and strong reimbursement coverage; California alone hosts several of the country's largest cryobank headquarters.

• •Known and open-identity donor programs are scaling rapidly, particularly in California, Colorado, and Connecticut.
• •International donor shipments from U.S. cryobanks remain an important revenue line, with growth focused on Europe and Latin America.

What are the recent trends and outlook?

The most visible trend is the migration toward donor matching through app- and website-based platforms that let recipients filter by detailed genetic, ancestral, physical, and personal attributes, and increasingly by open-identity or known-donor status. Genetic compatibility testing, expanded carrier screening, and microfluidic sperm sorting are lifting success rates and shifting competitive differentiation away from donor volume alone. Industry observers expect sustained 3-4% annual growth through the remainder of the decade, with the greatest expansion in open-identity and known-donor services and in direct-to-consumer distribution channels.

• •Post-2022 state-level limits on donor anonymity, starting with California, are reshaping donor recruitment and long-term recordkeeping.
• •Microfluidics-based sex-sorting and AI-assisted donor matching tools have moved from research into limited commercial pilots at several major U.S. cryobanks.